Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.

Fusco NM, Meaney CJ, Frederick CA, Prescott WA Jr.

Ann Pharmacother. 2019 Oct 29:1060028019885651. doi: 10.1177/1060028019885651. [Epub ahead of print]

PMID:
31658825
2.

Immunization Education in US Pharmacy Colleges and Schools.

Prescott WA Jr, Bernhardi C.

Am J Pharm Educ. 2019 Jun;83(5):6765. doi: 10.5688/ajpe6765.

3.

Comparing Pharmacotherapy Instruction to the 2009 and 2016 ACCP Toolkit Recommendations.

Woodruff AE, Albanese NP, Prescott WA Jr.

Am J Pharm Educ. 2018 Dec;82(10):6771. doi: 10.5688/ajpe6771.

4.

Pharmacokinetic Monitoring of Vancomycin in Cystic Fibrosis: Is It Time to Move Past Trough Concentrations?

Fusco NM, Prescott WA Jr, Meaney CJ.

Pediatr Infect Dis J. 2019 Mar;38(3):258-262. doi: 10.1097/INF.0000000000002088.

PMID:
29742643
5.

Vancomycin Versus Vancomycin Plus Rifampin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.

Fusco NM, Meaney CJ, Wells C, Frederick CA, Prescott WA Jr.

J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):125-131. doi: 10.5863/1551-6776-23.2.125.

6.

Characterization of Vaccination Policies for Attendance and Employment at Day/Summer Camps in New York State.

Prescott WA Jr, Violanti KC, Fusco NM.

J Pharm Pract. 2019 Aug;32(4):382-387. doi: 10.1177/0897190017751947. Epub 2018 Jan 11.

PMID:
29325483
7.

Comparison of prescribing patterns between United States and Dominican Republic prescribers on short-term medical mission trips.

Prescott GM, Patzke CL, Brody PM Jr, Prescott WA Jr.

Int Health. 2018 Jan 1;10(1):27-32. doi: 10.1093/inthealth/ihx045.

PMID:
29309591
8.

Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy.

Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Li Y, Ilmet T, Artimovich E, Neal J, Hall T, Parikh S, Kirmse B, Jean-Philippe P, Chen J, Prescott WR, Palumbo P, Duffy PE, Borkowsky W, For The P S Study Team.

Am J Trop Med Hyg. 2018 Jan;98(1):67-70. doi: 10.4269/ajtmh.17-0462.

9.

Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.

Fusco NM, Francisconi R, Meaney CJ, Duman D, Frederick CA, Prescott WA.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e103-e108. doi: 10.1093/jpids/pix043.

PMID:
28903517
10.

Global Health Education in Doctor of Pharmacy Programs in the United States.

Prescott GM, Vu BN, Alsharif NZ, Prescott WA Jr.

Am J Pharm Educ. 2017 Mar 25;81(2):28. doi: 10.5688/ajpe81228.

11.

Introduction and Assessment of a Blended-Learning Model to Teach Patient Assessment in a Doctor of Pharmacy Program.

Prescott WA Jr, Woodruff A, Prescott GM, Albanese N, Bernhardi C, Doloresco F.

Am J Pharm Educ. 2016 Dec 25;80(10):176. doi: 10.5688/ajpe8010176.

12.

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.

Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Petzold E, Barlow-Mosha L, Chi BH, Li Y, Ilmet T, Kirmse B, Neal J, Parikh S, Deygoo N, Jean Philippe P, Mofenson L, Prescott W, Chen J, Musoke P, Palumbo P, Duffy PE, Borkowsky W; P1068s Study Team.

PLoS One. 2016 Dec 9;11(12):e0165140. doi: 10.1371/journal.pone.0165140. eCollection 2016.

13.
14.

Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.

Fusco NM, Toussaint KA, Prescott WA Jr.

Ann Pharmacother. 2015 Apr;49(4):458-68. doi: 10.1177/1060028014567526. Epub 2015 Jan 12. Review.

PMID:
25583881
15.

A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.

Prescott WA Jr.

Respir Care. 2014 Sep;59(9):1353-9. doi: 10.4187/respcare.02980. Epub 2014 Apr 29.

16.

Education in pediatrics in US colleges and schools of pharmacy.

Prescott WA Jr, Dahl EM, Hutchinson DJ.

Am J Pharm Educ. 2014 Apr 17;78(3):51. doi: 10.5688/ajpe78351.

17.

Clinical impact of laboratory error on therapeutic drug monitoring of once-daily tobramycin in cystic fibrosis: Case series.

Prescott WA, Mancuso MA.

SAGE Open Med Case Rep. 2014 Jan 21;2:2050313X14521158. doi: 10.1177/2050313X14521158. eCollection 2014.

18.

Malaria diagnostics in clinical trials.

Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA.

Am J Trop Med Hyg. 2013 Nov;89(5):824-39. doi: 10.4269/ajtmh.12-0675. Epub 2013 Sep 23. Review.

19.

Inhaled aztreonam lysine: an evidence-based review.

Hutchinson D, Barclay M, Prescott WA, Brown J.

Expert Opin Pharmacother. 2013 Oct;14(15):2115-24. doi: 10.1517/14656566.2013.831070. Epub 2013 Aug 31. Review.

PMID:
23992352
20.

Impact of electronic device use in class on pharmacy students' academic performance.

Prescott WA Jr, Johnson HL, Wrobel MJ, Prescott GM.

Am J Pharm Educ. 2012 Nov 12;76(9):167. doi: 10.5688/ajpe769167.

21.

A mathematical framework for combining decisions of multiple experts toward accurate and remote diagnosis of malaria using tele-microscopy.

Mavandadi S, Feng S, Yu F, Dimitrov S, Nielsen-Saines K, Prescott WR, Ozcan A.

PLoS One. 2012;7(10):e46192. doi: 10.1371/journal.pone.0046192. Epub 2012 Oct 11.

22.

National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations.

Prescott WA Jr.

J Pediatr Pharmacol Ther. 2011 Oct;16(4):262-9. doi: 10.5863/1551-6776-16.4.262.

23.

Performance of a malaria microscopy image analysis slide reading device.

Prescott WR, Jordan RG, Grobusch MP, Chinchilli VM, Kleinschmidt I, Borovsky J, Plaskow M, Torrez M, Mico M, Schwabe C.

Malar J. 2012 May 6;11:155. doi: 10.1186/1475-2875-11-155.

24.

Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?

Prescott WA Jr, Hutchinson DJ.

J Pediatr Pharmacol Ther. 2011 Apr;16(2):77-86. doi: 10.5863/1551-6776-16.2.77.

25.

Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.

Prescott WA Jr, Gentile AE, Nagel JL, Pettit RS.

P T. 2011 Nov;36(11):723-63.

26.
27.

Preparing pharmacy graduates for traditional and emerging career opportunities.

Brazeau GA, Meyer SM, Belsey M, Bednarczyk EM, Bilic S, Bullock J, DeLander GE, Fiese EF, Giroux SL, McNatty D, Nemire R, Prescott WA Jr, Traynor AP.

Am J Pharm Educ. 2009 Dec 17;73(8):157.

28.

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review.

Prescott WA Jr, Doloresco F, Brown J, Paladino JA.

Pharmacoeconomics. 2010;28(4):279-93. doi: 10.2165/11531860-000000000-00000. Review.

PMID:
20131925
29.

Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.

Prescott WA Jr, Nagel JL.

Pharmacotherapy. 2010 Jan;30(1):95-108. doi: 10.1592/phco.30.1.95. Review.

PMID:
20030477
30.

Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.

Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, Leggat PA, Pickford P, Kerr C, Ohrt C, Prescott W; Tafenoquine Study Team.

Antimicrob Agents Chemother. 2010 Feb;54(2):792-8. doi: 10.1128/AAC.00354-09. Epub 2009 Dec 7.

31.

Safety of ceftriaxone sodium at extremes of age.

Monte SV, Prescott WA, Johnson KK, Kuhman L, Paladino JA.

Expert Opin Drug Saf. 2008 Sep;7(5):515-23. doi: 10.1517/14740338.7.5.515 . Review.

PMID:
18759704
32.

Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy.

Prescott WA Jr, Kusmierski KA.

Pharmacotherapy. 2007 Jan;27(1):137-42. Review.

PMID:
17192167
33.

Reader technique as a source of variability in determining malaria parasite density by microscopy.

O'Meara WP, Barcus M, Wongsrichanalai C, Muth S, Maguire JD, Jordan RG, Prescott WR, McKenzie FE.

Malar J. 2006 Dec 12;5:118.

34.

Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency.

Maguire JD, Lederman ER, Barcus MJ, O'Meara WA, Jordon RG, Duong S, Muth S, Sismadi P, Bangs MJ, Prescott WR, Baird JK, Wongsrichanalai C.

Malar J. 2006 Oct 25;5:92.

35.

Antiinflammatory therapies for cystic fibrosis: past, present, and future.

Prescott WA Jr, Johnson CE.

Pharmacotherapy. 2005 Apr;25(4):555-73. Review.

36.

The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.

Prescott WA Jr, Streetman DA, Streetman DS.

Ann Pharmacother. 2004 Dec;38(12):2105-14. Epub 2004 Oct 26. Review.

PMID:
15507504
37.

Sincalide in patients with parenteral nutrition-associated gallbladder disease.

Prescott WA Jr, Btaiche IF.

Ann Pharmacother. 2004 Nov;38(11):1942-5. Epub 2004 Aug 17. Review.

PMID:
15316105
38.

Tacrolimus toxicity associated with concomitant metoclopramide therapy.

Prescott WA Jr, Callahan BL, Park JM.

Pharmacotherapy. 2004 Apr;24(4):532-7.

39.

Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy.

Prescott WA Jr, DePestel DD, Ellis JJ, Regal RE.

Clin Infect Dis. 2004 Apr 15;38(8):1102-7. Epub 2004 Mar 26.

PMID:
15095214
40.

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.

Hale BR, Owusu-Agyei S, Fryauff DJ, Koram KA, Adjuik M, Oduro AR, Prescott WR, Baird JK, Nkrumah F, Ritchie TL, Franke ED, Binka FN, Horton J, Hoffman SL.

Clin Infect Dis. 2003 Mar 1;36(5):541-9. Epub 2003 Feb 14.

PMID:
12594633
41.

Psychologist prescribing: the issues in Maryland.

Prescott WG.

Md Med. 2002 Fall;3(4):26-8. No abstract available.

PMID:
12481744
42.

Who's the boss?

Pride JR, Prescott W.

Dent Econ. 1998 Mar;88(3):16, 19, 22-4. No abstract available.

PMID:
9709584
43.

The basics of hiring and firing.

Prescott WP.

J Calif Dent Assoc. 1996 Jul;24(7):21-5.

PMID:
9052009
44.

The law and managed care plans.

Prescott WP.

J Calif Dent Assoc. 1995 Jun;23(6):33-8. No abstract available.

PMID:
10371925
45.

Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

Martin BR, Compton DR, Prescott WR, Barrett RL, Razdan RK.

Drug Alcohol Depend. 1995 Mar;37(3):231-40.

PMID:
7796717
46.

Quantitation of rodent catalepsy by a computer-imaging technique.

Martin BR, Prescott WR, Zhu M.

Pharmacol Biochem Behav. 1992 Oct;43(2):381-6.

PMID:
1332079
47.

Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.

Prescott WR, Gold LH, Martin BR.

Psychopharmacology (Berl). 1992;107(1):117-24.

PMID:
1317040
48.

Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.

Balster RL, Prescott WR.

Neurosci Biobehav Rev. 1992 Spring;16(1):55-62. Review.

PMID:
1313164
49.

Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.

Compton DR, Prescott WR Jr, Martin BR, Siegel C, Gordon PM, Razdan RK.

J Med Chem. 1991 Nov;34(11):3310-6.

PMID:
1659638
50.

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ.

Pharmacol Biochem Behav. 1991 Nov;40(3):471-8.

PMID:
1666911

Supplemental Content

Loading ...
Support Center